Efficacy of ferric carboxymaltose for the treatment of IBD-related iron deficiency anaemia
Latest Information Update: 13 Dec 2016
At a glance
- Drugs Ferric carboxymaltose (Primary)
- Indications Iron deficiency anaemia
- Focus Therapeutic Use
- 13 Dec 2016 New trial record
- 19 Oct 2016 Primary endpoint of normalisation of serum ferritin and transferrin saturation has been met, according to results presented at the 24th United European Gastroenterology Week.
- 19 Oct 2016 Primary endpoint of normalisation of Hb or increase of 2 g/dL has been met, according to results presented at the 24th United European Gastroenterology Week.